Who owns Capstone Therapeutics Corporat?
- Ticker: CAPS
- CUSIP Number: 14068e208
Tip: Access positions for across all investors
Analyze quarterly positions in Capstone Therapeutics Corporat with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Capstone Therapeutics Corporat stock
Who bought or sold Capstone Therapeutics Corporat this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Pensionmark Financial Group | 29k | $38k | 100% | Sep 2025 |
|
| Citadel Advisors | 16k | $21k | 100% | Sep 2025 |
|
| Two Sigma Securities | 12k | $15k | 100% | Sep 2025 |
|
| Two Sigma Investments | 11k | $14k | 2% | Sep 2025 |
|
| Tower Research Capital | 5.5k | $7.3k | 2041% | Sep 2025 |
|
| UBS Group | 2.5k | $3.3k | 2% | Sep 2025 |
|
| Morgan Stanley | 1.00 | $2.000000 | 100% | Jun 2025 |
|